TR199802019T2 - Terapötik amidleri stereoselektif olarak hazirlamak için enzimatik yöntem. - Google Patents

Terapötik amidleri stereoselektif olarak hazirlamak için enzimatik yöntem.

Info

Publication number
TR199802019T2
TR199802019T2 TR1998/02019T TR9802019T TR199802019T2 TR 199802019 T2 TR199802019 T2 TR 199802019T2 TR 1998/02019 T TR1998/02019 T TR 1998/02019T TR 9802019 T TR9802019 T TR 9802019T TR 199802019 T2 TR199802019 T2 TR 199802019T2
Authority
TR
Turkey
Prior art keywords
enzymatic method
preparing therapeutic
stereoselectively preparing
formula
amides
Prior art date
Application number
TR1998/02019T
Other languages
English (en)
Inventor
Crosby John
Antony Holt Robert
David Pittam John
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Limited filed Critical Zeneca Limited
Publication of TR199802019T2 publication Critical patent/TR199802019T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/14—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and esterified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)

Abstract

Bu bulus, formül I'e sahip optikce aktif bilesikler hazirlamaya mahsus enzimatik yöntemler saglar; bu formülde X E ve *, tarifname içinde tanimlanmis anlamlara sahiptir. Bu bulus ayrica Formül I'e sahip bilesikleri hazirlamak için yararli olan kiral arabilesikler ve bu gibi kiral arabilesikleri hazirlamaya mahsus enzimatik yöntemler saglar.
TR1998/02019T 1996-04-10 1997-04-07 Terapötik amidleri stereoselektif olarak hazirlamak için enzimatik yöntem. TR199802019T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9607458.8A GB9607458D0 (en) 1996-04-10 1996-04-10 Enzymatic process for stereoselective preparation of therapeutic amides

Publications (1)

Publication Number Publication Date
TR199802019T2 true TR199802019T2 (tr) 1999-04-21

Family

ID=10791844

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02019T TR199802019T2 (tr) 1996-04-10 1997-04-07 Terapötik amidleri stereoselektif olarak hazirlamak için enzimatik yöntem.

Country Status (22)

Country Link
US (2) US6110729A (tr)
EP (1) EP0904400B1 (tr)
JP (3) JP3896162B2 (tr)
KR (1) KR20000005286A (tr)
CN (1) CN1215434A (tr)
AR (1) AR008756A1 (tr)
AT (1) ATE291095T1 (tr)
AU (1) AU723526B2 (tr)
BR (1) BR9708532A (tr)
CA (1) CA2251634A1 (tr)
CZ (1) CZ324698A3 (tr)
DE (1) DE69732772T2 (tr)
GB (1) GB9607458D0 (tr)
IL (1) IL126451A0 (tr)
MY (1) MY133666A (tr)
NO (1) NO984712L (tr)
NZ (1) NZ331401A (tr)
PL (1) PL329290A1 (tr)
SK (1) SK140198A3 (tr)
TR (1) TR199802019T2 (tr)
WO (1) WO1997038124A2 (tr)
ZA (1) ZA973019B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1175889A (ja) * 1997-07-15 1999-03-23 Mitsubishi Rayon Co Ltd 光学活性α−トリフルオロメチル乳酸及びその対掌体エステルの製造方法及び精製方法
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
EP1074539B1 (en) 1999-08-04 2007-10-17 Sumitomo Chemical Company, Limited Process for producing optically active 3,3,3,-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof
DE60031699T2 (de) 1999-09-04 2007-08-30 Astrazeneca Ab Hydroxyacetamidobenzolsulfonamidderivate
AU6715200A (en) 1999-09-04 2001-04-10 Astrazeneca Ab Amides as inhibitors for pyruvate dehydrogenase
CZ2002773A3 (cs) 1999-09-04 2002-06-12 Astrazeneca Ab Substituované deriváty N-fenyl-2-hydroxy-2-methyl-3,3,3-trifluorpropanamidu, které zvyąují aktivitu pyruvátdehydrogenázy
EP1422226A1 (en) * 2002-11-25 2004-05-26 Tosoh Corporation Optically active fluorine-containing compounds and processes for their production
JP4529419B2 (ja) * 2002-11-25 2010-08-25 東ソー株式会社 光学活性含フッ素化合物類、及びこれらの製造方法
JP2007217440A (ja) * 2007-06-06 2007-08-30 Mitsubishi Rayon Co Ltd 光学活性α−トリフルオロメチル乳酸の精製方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2541466A (en) * 1949-05-21 1951-02-13 Eastman Kodak Co Alpha-fluoromethyl acrylonitriles and copolymers thereof
JPS59205989A (ja) * 1983-05-09 1984-11-21 Sumitomo Chem Co Ltd 光学活性なアルコ−ル化合物の生化学的製法
DE3528265A1 (de) * 1985-08-07 1987-02-12 Bayer Ag Phosphonsaeureester
US4929760A (en) * 1987-11-24 1990-05-29 Showa Shell Sekiyu Kabushiki Kaisha Fluorine-containing carbonyl compounds and method for preparing the same
JPH03254694A (ja) * 1990-03-01 1991-11-13 Kurita Water Ind Ltd 光学活性な含フッ素アルコールの製造方法
GB9005467D0 (en) * 1990-03-12 1990-05-09 Ici Plc Process for the preparation of optically active intermediates for insecticidal compounds
JP3010497B2 (ja) * 1990-05-31 2000-02-21 チッソ株式会社 光学活性α―ヒドロキシエステル類の製造方法
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
US5334534A (en) * 1992-04-15 1994-08-02 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Enzymatic preparation of optically active propanolol and β-adrenergic blockers using esterase
JP3133480B2 (ja) * 1992-04-15 2001-02-05 昭和シェル石油株式会社 光学活性ハロゲン含有アルコールの製造方法
GB9304256D0 (en) * 1993-03-03 1993-04-21 Chiros Ltd Arylalkanoic acid resolution
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
ES2121212T3 (es) * 1993-07-02 1998-11-16 Unichema Chemie Bv Proceso para la esterificacion de acidos carboxilicos con alcoholes terciarios.
BE1007297A3 (nl) * 1993-07-19 1995-05-09 Dsm Nv Werkwijze voor de bereiding van optisch aktieve alcoholen en esters, en alcoholen en esters toegepast en bereid in dergelijke werkwijzen.
GB9322472D0 (en) * 1993-11-01 1993-12-22 Chiros Ltd Chiral compounds and their preparation

Also Published As

Publication number Publication date
WO1997038124A2 (en) 1997-10-16
ZA973019B (en) 1997-10-10
DE69732772D1 (de) 2005-04-21
CA2251634A1 (en) 1997-10-16
PL329290A1 (en) 1999-03-15
MY133666A (en) 2007-11-30
NO984712D0 (no) 1998-10-09
DE69732772T2 (de) 2005-10-27
GB9607458D0 (en) 1996-06-12
US6110729A (en) 2000-08-29
BR9708532A (pt) 1999-08-03
AU2302897A (en) 1997-10-29
CN1215434A (zh) 1999-04-28
JP2006345873A (ja) 2006-12-28
JP2000509254A (ja) 2000-07-25
KR20000005286A (ko) 2000-01-25
AU723526B2 (en) 2000-08-31
AR008756A1 (es) 2000-02-23
IL126451A0 (en) 1999-08-17
NO984712L (no) 1998-10-09
SK140198A3 (en) 1999-03-12
ATE291095T1 (de) 2005-04-15
CZ324698A3 (cs) 1999-01-13
JP3896162B2 (ja) 2007-03-22
US6261830B1 (en) 2001-07-17
EP0904400B1 (en) 2005-03-16
NZ331401A (en) 2000-06-23
EP0904400A2 (en) 1999-03-31
WO1997038124A3 (en) 1997-12-18
JP2005287514A (ja) 2005-10-20

Similar Documents

Publication Publication Date Title
FR18C1021I2 (fr) Methode de regulation de l'activite d'une molecule immunologiquement fonctionnelle
ATE271058T1 (de) Mycophenol bisphosponatverbindungen
EA200001176A1 (ru) Гетероциклические ингибиторы p38
NO975716D0 (no) Imidazolforbindelser
DK0741694T3 (da) Phenyleddikesyrederivater, fremgangsmåder og mellemprodukter til deres fremstilling og midler indeholdende disse
DK1200479T3 (da) Multiple cytokin-antistof-komplekser
TR199801255T2 (tr) Vitronektin reseptör antagonistleri.
EA199900643A1 (ru) Сульфамидные ингибиторы металлопротеаз
TR199900856T2 (tr) Bronsla ilgili terapi maddeleri olarak benzonaftiridinler
DK1083903T3 (da) Brobundne indenopyrrolocarbazoler
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
ATE402149T1 (de) Heterozyklische substituierte amide, deren herstellung und anwendung
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
AU4279996A (en) New method for identifying and evaluating biologically active molecules
TR200600582A1 (tr) N-(4-tiriflormetilfenil)-5-metil-[zoksazol-4-karboksamidin kristal formu
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
EA200000522A1 (ru) 5-htагонисты
BR0114884A (pt) Compostos calcilìticos
PT950056E (pt) N-(piridinilamino) isoindolinas e compostos relacionados
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
ATE198911T1 (de) Verfahren zur herstellung von optisch aktiven aminen
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
TR200103126T2 (tr) Yapısal titremenin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri
DE69904635D1 (de) Derivate von aromaten und deren eisen komplexe zur verwendung als regulierungsmittel des eisenspiegels